Mitomycin C in the treatment of keloids: a case and review.

Mitomycin C in the treatment of keloids: a case and review.

Journal of drugs in dermatology : JDD (2013-07-11)

Rebecca Kleinerman, Suzanne L Kilmer, Vera A Chotzen

RÉSUMÉ

Mitomycin C (MMC) is an antineoplastic antibiotic that has been used off-label in the treatment of hypertrophic scars and keloids. Herein we report our successful use of this agent in a patient with sternal keloids refractory to other means of therapy. We further review the literature regarding the use of MMC in the treatment of keloids.

MATÉRIAUX

Référence du produit

Marque

Description du produit

M4287

Sigma-Aldrich

Mitomycine C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture

M7949

Sigma-Aldrich

Mitomycine C from Streptomyces caespitosus, ≥98% (HPLC), potency: ≥970 μg per mg (USP XXIV), γ-irradiated, suitable for cell culture

M0503

Sigma-Aldrich

Mitomycine C from Streptomyces caespitosus, powder, contains NaCl as solubilizer

M0440

Sigma-Aldrich

Mitomycine C from Streptomyces caespitosus, meets USP testing specifications

Y0000378

Mitomycine C, European Pharmacopoeia (EP) Reference Standard